[Development and implementation of a regional medical collaboration platform for hematological malignancies].

To address the challenges of regional collaboration in the treatment of hematologic malignancies, we conducted a prospective clinical study of a healthcare communication platform (Dr2GO®) designed to ensure seamless continuity of care by streamlining inter-hospital transfer coordination. By the end of 2024, nineteen patients were enrolled across the four participating institutions. The most frequently used clinical pathway was vaccination after allogeneic hematopoietic stem cell transplantation (7 cases). The median time from the referral request by the hub hospital to confirmation by the community institution was 15 hours. Among the cases requested during regular working hours, 83% were confirmed within 30 minutes. The median duration of pathway continuation was 9.5 months, with a continuation rate of 78.9%. In a survey, 75% of respondents reported faster medical coordination. During the study period, 26 chat entries were recorded, with a median of one entry per patient. These findings suggest that the Dr2GO®-based electronic clinical pathway both facilitates rapid transfer coordination and efficient information sharing, while potentially reducing physician workload and promoting task shifting.